Adaptive Biotech CEO says it’s working to develop the best antibody treatment for Covid-19

Adaptive biotechnologies CEO Chad Robins says the company is working night and day to develop an effective antibody Covid-19 treatment. He says the company won't be first to provide antibody treatments, but once developed it will help many patients across the United States. He joins 'Closing Bell' to discuss.